What question did this study set out to answer?

The study aims to evaluate treatment patterns and clinical outcomes for individuals with Haemophilia A without inhibitors.

April 1, 2026

View Full Paper

Treatment of Haemophilia A Without Inhibitors: Real‐World Treatment Patterns and Clinical Outcomes in the US

AWAllison P. WheelerUniversity of Washington LALauren E. AmosChildren's Mercy Hospital SGShveta GuptaArnold Palmer Hospital for Children

Key Points

The study aims to evaluate treatment patterns and clinical outcomes for individuals with Haemophilia A without inhibitors.
Observed real-world bleeding events over the year
Assessed quality of life for participants
Categorized participants based on prophylaxis product class
Most participants experienced at least one bleeding event annually
Quality of life was reported as reduced among participants
Indicates the need for better treatment strategies

Abstract

Regardless of the prophylaxis product class used, most participants experienced ≥1 bleeding event per year and reduced QoL. Further treatment optimisation may be needed to prevent bleeding episodes and improve patient QoL.

AI에게 질문

Bookmark

View Full Paper

AI에게 질문

Bookmark

View Full Paper

Treatment of Haemophilia A Without Inhibitors: Real‐World Treatment Patterns and Clinical Outcomes in the US

Key Points

Abstract

Cite This Study

Also Consider

Also Consider